The relationship between trial registration and publication is not straightforward. Although registries and editorial requirements receive some attention from researchers, study protocol changes, ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...